NCT07147868

Brief Summary

Aim: To evaluate the effects of structured education provided to the relatives of chemotherapy patients on family health, nutrition, and psychological well-being. Methods: This randomized controlled study will be conducted with a parallel-group, pretest-posttest design at a university hospital in the northeastern region of Turkey. A total of 68 patient relatives are planned to participate (Intervention: 34, Control: 34). The training to be provided to the intervention group will cover topics such as self-efficacy, nutrition, and stress management. Data will be collected at three different time points (pretest, mid-test, posttest) using the Family Health Scale (FHS), the Mediterranean Diet Adherence Screener (MEDAS), and the Psychological Well-Being Scale (PWB). Statistical analyses will include chi-square tests, t-tests, and Pearson correlation coefficients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
171

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 10, 2025

Completed
22 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 4, 2025

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 18, 2025

Completed
28 days until next milestone

First Submitted

Initial submission to the registry

August 15, 2025

Completed
14 days until next milestone

First Posted

Study publicly available on registry

August 29, 2025

Completed
Last Updated

September 8, 2025

Status Verified

August 1, 2025

Enrollment Period

22 days

First QC Date

August 15, 2025

Last Update Submit

August 30, 2025

Conditions

Keywords

Chemotherapycaregiver educationfamily healthpsychological well-beingnutrition

Outcome Measures

Primary Outcomes (3)

  • Psychological Well-Being Score

    Description: Change in psychological well-being of caregivers, measured using the Psychological Well-Being Scale, an 8-item, 7-point Likert scale (scores range from 8 to 56, higher scores indicate better well-being). The scale assesses life satisfaction, stress coping, and positive emotions.

    Baseline (t0), immediately post-intervention (t1), and 6 weeks post-intervention (t2).

  • Mediterranean Diet Adherence Score

    Change in adherence to the Mediterranean diet among caregivers, measured using the Mediterranean Diet Adherence Scale, a 14-item scale (scores range from 0 to 14, higher scores indicate greater adherence). Scores ≥7 indicate acceptable adherence, and ≥9 indicate high adherence.

    Time Frame: Baseline (t0), immediately post-intervention (t1), and 6 weeks post-intervention (t2).

  • Family Health Score

    Change in family health levels among caregivers, measured using the Family Health Scale (FHS), short form (FHS-SF), a 10-item scale (scores range from 10 to 50, dichotomized to 0-10 for evaluation: 0-5 = poor, 6-8 = moderate, 9-10 = excellent family health).

    Baseline (t0), immediately post-intervention (t1), and 6 weeks post-intervention (t2).

Secondary Outcomes (3)

  • Correlation Between Psychological Well-Being and Family Health

    Baseline (t0), immediately post-intervention (t1), and 6 weeks post-intervention (t2).

  • Correlation Between Psychological Well-Being and Mediterranean Diet Adherence

    Baseline (t0), immediately post-intervention (t1), and 6 weeks post-intervention (t2).

  • Correlation Between Family Health and Mediterranean Diet Adherence

    Baseline (t0), immediately post-intervention (t1), and 6 weeks post-intervention (t2).

Study Arms (2)

Arm 1 (Experimental): Structured Caregiver Education Arm 2 (Control): No Structured Education

EXPERIMENTAL

Arm Type: Experimental Relatives of chemotherapy patients received a structured training program covering self-efficacy, nutrition, and stress management. The training was delivered in group sessions supported by educational materials.

Behavioral: Structured Education Program for Caregivers of Chemotherapy Patients

Control Group (No Intervention)

NO INTERVENTION

Relatives of chemotherapy patients received standard care without additional structured training.

Interventions

A structured educational intervention designed for caregivers of cancer patients undergoing chemotherapy, delivered in 30-45 minute sessions to groups of 4-5 participants. The program includes modules on self-efficacy, stress management, healthy lifestyle behaviors, interpersonal relationships, and nutrition based on the Mediterranean diet. Content covers evidence-based strategies for improving family health, psychological well-being, and dietary adherence. Sessions are conducted by a certified practitioner with 480 hours of family counseling training in a university hospital's medical oncology unit seminar room. The intervention aims to reduce caregiver burden, enhance psychological well-being, improve adherence to the Mediterranean diet, and promote family health, as assessed by the Family Health Scale (ASÖ), Mediterranean Diet Adherence Scale (MEDAS), and Psychological Well-Being Scale (PİO) at baseline (t0), post-intervention (t1), and 6 weeks follow-up (t2).

Arm 1 (Experimental): Structured Caregiver Education Arm 2 (Control): No Structured Education

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Caregiver (first-degree relative or emotional supporter) of a patient receiving chemotherapy.
  • Age 18 years or older.
  • Ability to read and understand Turkish.
  • Provides care or emotional support to the chemotherapy patient.
  • No chronic health conditions.
  • Not receiving psychiatric treatment.
  • No substance use.

You may not qualify if:

  • Presence of cognitive or sensory impairments.
  • Failure to attend at least two education sessions (for intervention group).
  • Pregnancy.
  • Voluntary withdrawal from the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Van Yuzuncu Yil University Hospital

Van, 65100, Turkey (Türkiye)

Location

Related Publications (1)

  • Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.

Related Links

MeSH Terms

Conditions

Psychological Well-Being

Condition Hierarchy (Ancestors)

Personal SatisfactionBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Participants were randomly assigned to intervention or control groups and assessed at baseline, mid-intervention, and post-intervention
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Prof. Dr.

Study Record Dates

First Submitted

August 15, 2025

First Posted

August 29, 2025

Study Start

February 10, 2025

Primary Completion

March 4, 2025

Study Completion

July 18, 2025

Last Updated

September 8, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

There is no plan to share individual participant data (IPD) with other researchers. The study collected sensitive data, including sociodemographic information, psychological well-being scores, Mediterranean diet adherence scores, and family health scores, from caregivers of chemotherapy patients. Data sharing is not planned due to privacy and ethical considerations, as participant confidentiality is protected under the ethical approvals obtained from the X University Health Sciences Research and Publication Ethics Committee and in accordance with the Helsinki Declaration.

Locations